The 15th of September marked the beginning of Rheumatoid Arthritis Awareness Week, an event launched by the National Rheumatoid Arthritis Society (NRAS) in 2013 to educate on the symptoms and ...
Drug Discovery News spoke with John Stone, MD MPH, Chair of the Scientific Advisory Board at Steritas, to discuss the origins and impact of the GTI. To read the full interview, click here.
During EULAR 2025, Steritas will present key data about how Sam (steroidsandme.com) is equipping steroid-treated patients to work with their doctors. The poster, A Patient-Focused Program for Using ...
American Pharmaceutical Review publishes an article by John H. Stone, MD MPH, Chair of the Steritas Scientific Advisory Board. You can read the article here. Full reference: American Pharmaceutical ...
John Stone, MD MPH, Chair of Steritas Scientific Board, discusses the true cost of steroid-toxicity with Drug Discovery & Development (DD&D). Read the full article here.
Steritas' John Stone analyses the benefits that a quantifiable index system can have for researchers looking into steroid toxicity, and how this can allow them to work with larger sets of patient ...